Wolverine Blend (BPC-157 / TB-500)
Also known as · BPC-157 + TB-500 · Wolverine 20mg
Overview
A 1:1 (10 mg / 10 mg) co-lyophilized blend of BPC-157 and TB-500 studied in preclinical models for combined effects on angiogenesis, tendon/ligament remodeling, and soft-tissue repair.
Research profile · for clinicians
Based on research: a 1:1 tissue-repair combination studied preclinically for additive effects on angiogenesis, tendon and ligament remodeling, and soft-tissue recovery — pairing BPC-157's NO/VEGF signaling with TB-500's actin-mediated cell-migration effects.
Mechanism of action
BPC-157 modulates the nitric-oxide system and upregulates growth-factor receptors; TB-500 (a thymosin-β4 fragment) promotes G-actin sequestration, endothelial migration, and angiogenesis. Combined preparations are studied for additive repair signaling.
Research record
- [01]Preclinical tendon, ligament, and muscle repair models for each constituent.
- [02]No published clinical trials of the fixed-ratio blend in humans.
Selected references
BPC 157 and tissue protection
Curr. Pharm. Des., 2018
Thymosin β4 in wound healing
Ann. N.Y. Acad. Sci., 2012
Research deep dive
Every cited study, explained
Plain-language walkthroughs of each reference, with direct PubMed links and dosing-literature context.